U.S. Covid-19 Vaccine Development Tools Market Size & Outlook
U.S. covid-19 vaccine development tools market, 2020-2028 (US$M)
Related Markets
U.S. covid-19 vaccine development tools market highlights
- The U.S. covid-19 vaccine development tools market generated a revenue of USD 4,274.7 million in 2020 and is expected to reach USD 8,197.7 million by 2028.
- The U.S. market is expected to grow at a CAGR of 8.5% from 2021 to 2028.
- In terms of segment, laboratory technologies was the largest revenue generating technologies in 2020.
- Online Technologies is the most lucrative technologies segment registering the fastest growth during the forecast period.
Covid-19 vaccine development tools market data book summary
| Market revenue in 2020 | USD 4,274.7 million |
| Market revenue in 2028 | USD 8,197.7 million |
| Growth rate | 8.5% (CAGR from 2020 to 2028) |
| Largest segment | Laboratory technologies |
| Fastest growing segment | Online Technologies |
| Historical data | 2020 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Laboratory Technologies, Online Technologies |
| Key market players worldwide | Thermo Fisher Scientific Inc, Pfizer Inc, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Merck KGaA, Qiagen NV, Shimadzu Corp, Eurofins Scientific SE, Charles River Laboratories International Inc, Takara Bio Inc, Olympus Corp, Avantor Inc, Aurora Innovation Inc Class A, Standard BioTools Inc, Celerion, Cole-Parmer, Hartford Schroders International Stk I, Revvity Inc, Fluidigm Corporation, Polyplus-transfection, Hamilton Lane Inc Class A |
Other key industry trends
- In terms of revenue, U.S. accounted for 26.7% of the global covid-19 vaccine development tools market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. covid-19 vaccine development tools market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 514.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
COVID-19 Vaccine Development Tools Market Scope
COVID-19 Vaccine Development Tools Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. covid-19 vaccine development tools market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 vaccine development tools market will help companies and investors design strategic landscapes.
Laboratory technologies was the largest segment with a revenue share of 95.01% in 2020. Horizon Databook has segmented the U.S. covid-19 vaccine development tools market based on laboratory technologies, online technologies covering the revenue growth of each sub-segment from 2020 to 2028.
The U.S. is anticipated to be a competitive market in 2022 for COVID-19 vaccine development. Pfizer, Biotech, and Moderns are key players that accelerated competition on the basis of differentiation, pan-variant shots, and global distribution.
For instance, Pfizer and Biotech collaborated to develop a COVID-19 vaccine, the BNT162b2 mRNA vaccine program, and Pfizer-Biotech COVID-19 Vaccine, for children aged 0.6 to 4 in the U.S. The Pfizer-Biotech COVID-19 Vaccine was developed through Biotech's proprietary mRNA technology, which was developed by Pfizer and Biotech as an integrated project.
In February 2022, the companies filed for U.S. FDA approval for EUA for Pfizer-Biotech COVID19 Vaccine. As of January 2022, a total of 140 vaccines are under clinical development and 194 in preclinical development, including 10 mRNA-based vaccines of Pfizer and Moderns, which are in phase IV.
Reasons to subscribe to U.S. covid-19 vaccine development tools market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. covid-19 vaccine development tools market databook
-
Our clientele includes a mix of covid-19 vaccine development tools market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. covid-19 vaccine development tools market , including forecasts for subscribers. This country databook contains high-level insights into U.S. covid-19 vaccine development tools market from 2020 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. covid-19 vaccine development tools market size, by technologies, 2020-2028 (US$M)
U.S. COVID-19 Vaccine Development Tools Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
